| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1040747246 |
| P356 | DOI | 10.1038/CR.2013.25 |
| P932 | PMC publication ID | 3616436 |
| P698 | PubMed publication ID | 23419516 |
| P5875 | ResearchGate publication ID | 235658159 |
| P50 | author | Josef Penninger | Q1674391 |
| Zhen Zou | Q43182509 | ||
| P2093 | author name string | Xuezhong Yu | |
| Wei Wang | |||
| Chen Wang | |||
| Chenggang Li | |||
| Xiang Gao | |||
| Yan Zhao | |||
| Taisheng Li | |||
| Zhong Wang | |||
| Yanli Zhang | |||
| Bin Cao | |||
| Li Xing | |||
| Penghui Yang | |||
| Xiliang Wang | |||
| Zhongpeng Zhao | |||
| Chengyu Jiang | |||
| Ying Zhong | |||
| P2860 | cites work | IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking | Q28208563 |
| Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia | Q28262914 | ||
| Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study | Q28269717 | ||
| Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus | Q28283850 | ||
| Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. | Q30382272 | ||
| Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. | Q30383368 | ||
| Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. | Q30385421 | ||
| Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008-2009 (H1N1), and 2007-2008 (H3N2) infections | Q30393399 | ||
| IL-17 response mediates acute lung injury induced by the 2009 pandemic influenza A (H1N1) virus. | Q30408586 | ||
| Corticosteroid treatment ameliorates acute lung injury induced by 2009 swine origin influenza A (H1N1) virus in mice | Q30421004 | ||
| CXCL10-CXCR3 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral origin | Q37590959 | ||
| Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome | Q38440721 | ||
| Influenza A virus H5N1 entry into host cells is through clathrin-dependent endocytosis | Q39846750 | ||
| IP-10 correlates with hepatitis C viral load, hepatic inflammation and fibrosis and predicts hepatitis C virus relapse or non-response in HIV-HCV coinfection. | Q42985060 | ||
| A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis | Q82837990 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 577-580 | |
| P577 | publication date | 2013-02-19 | |
| P1433 | published in | Cell Research | Q1524018 |
| P1476 | title | Monoclonal antibody against CXCL-10/IP-10 ameliorates influenza A (H1N1) virus induced acute lung injury | |
| P478 | volume | 23 |
| Q41877735 | Adipokines and obesity are associated with colorectal polyps in adult males: a cross-sectional study |
| Q42216434 | Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients |
| Q34499803 | Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury |
| Q42213454 | Anti-inflammatory effect of thalidomide on H1N1 influenza virus-induced pulmonary injury in mice |
| Q40844952 | Anti-inflammatory effects of indirubin derivatives on influenza A virus-infected human pulmonary microvascular endothelial cells |
| Q45325042 | Basic fibroblast growth factor protects against influenza A virus-induced acute lung injury by recruiting neutrophils |
| Q59351169 | Delayed oseltamivir plus sirolimus treatment attenuates H1N1 virus-induced severe lung injury correlated with repressed NLRP3 inflammasome activation and inflammatory cell infiltration |
| Q40197433 | Detection methods of Cyprinid herpesvirus 2 infection in silver crucian carp (Carassius auratus gibelio) via a pORF72 monoclonal antibody. |
| Q39029296 | Development and characterization of two monoclonal antibodies against grouper iridovirus 55L and 97L proteins |
| Q47555467 | Differential responses of innate immunity triggered by different subtypes of influenza a viruses in human and avian hosts |
| Q94563280 | Erucic acid from Isatis indigotica Fort. suppresses influenza A virus replication and inflammation in vitro and in vivo through modulation of NF-κB and p38 MAPK pathway |
| Q41680476 | Evaluation of plasma exchange and continuous veno-venous hemofiltration for the treatment of severe avian influenza A (H7N9): a cohort study |
| Q38761111 | FAT10 Is Critical in Influenza A Virus Replication by Inhibiting Type I IFN. |
| Q33799030 | IL-36 receptor deletion attenuates lung injury and decreases mortality in murine influenza pneumonia |
| Q90356659 | Identification of amitriptyline HCl, flavin adenine dinucleotide, azacitidine and calcitriol as repurposing drugs for influenza A H5N1 virus-induced lung injury |
| Q35938048 | Influenza H3N2 infection of the collaborative cross founder strains reveals highly divergent host responses and identifies a unique phenotype in CAST/EiJ mice |
| Q42687063 | Lung Metabolic Activation as an Early Biomarker of Acute Respiratory Distress Syndrome and Local Gene Expression Heterogeneity. |
| Q41196865 | Mouse lung slices: An ex vivo model for the evaluation of antiviral and anti-inflammatory agents against influenza viruses |
| Q94490744 | Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19 |
| Q91782536 | Ponatinib Protects Mice From Lethal Influenza Infection by Suppressing Cytokine Storm |
| Q30398612 | Proinflammatory chemokines are major mediators of exuberant immune response associated with Influenza A (H1N1) pdm09 virus infection. |
| Q57930420 | Re-understanding anti-influenza strategy: attach equal importance to antiviral and anti-inflammatory therapies |
| Q94547260 | Sinensetin suppresses influenza a virus-triggered inflammation through inhibition of NF-κB and MAPKs signalings |
| Q48210833 | Surfactant Protein A Prevents IFN-γ/IFN-γ Receptor Interaction and Attenuates Classical Activation of Human Alveolar Macrophages. |
| Q91729703 | The Establishment and Validation of the Human U937 Cell Line as a Cellular Model to Screen Immunomodulatory Agents Regulating Cytokine Release Induced by Influenza Virus Infection |
| Q30652541 | The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes |
| Q58600025 | The emergence of pathogenic TNF/iNOS producing dendritic cells (Tip-DCs) in a malaria model of acute respiratory distress syndrome (ARDS) is dependent on CCR4 |
| Q26766467 | The host immune response in respiratory virus infection: balancing virus clearance and immunopathology. |
| Q100697759 | The role of dysregulated immune responses in COVID-19 pathogenesis |
| Q45324460 | miR-194 Inhibits Innate Antiviral Immunity by Targeting FGF2 in Influenza H1N1 Virus Infection |
Search more.